Clarivate (CLVT) to Announce Quarterly Earnings on Wednesday

Clarivate (NYSE:CLVT) is expected to release its Q2 2026 results before the market opens on Wednesday, July 29th. Analysts expect Clarivate to post earnings of $0.17 per share and revenue of $589.7290 million for the quarter. Clarivate has set its FY 2026 guidance at 0.700-0.800 EPS. Parties can find conference call details on the company’s upcoming Q2 2026 earning report for the latest details on the call scheduled for Wednesday, July 29, 2026 at 9:30 AM ET.

Clarivate (NYSE:CLVT) last announced its quarterly earnings results on Wednesday, April 29th. The company reported $0.18 EPS for the quarter, beating analysts’ consensus estimates of $0.14 by $0.04. The company had revenue of $585.50 million for the quarter, compared to analysts’ expectations of $569.50 million. Clarivate had a negative net margin of 5.61% and a positive return on equity of 8.82%. Clarivate’s revenue was down 1.4% compared to the same quarter last year. During the same period in the prior year, the company posted $0.14 EPS. On average, analysts expect Clarivate to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Clarivate Stock Up 4.2%

CLVT opened at $2.12 on Tuesday. Clarivate has a 12 month low of $1.66 and a 12 month high of $4.77. The company has a market cap of $1.36 billion, a PE ratio of -10.12 and a beta of 1.38. The company has a current ratio of 0.84, a quick ratio of 0.84 and a debt-to-equity ratio of 0.89. The company has a 50 day moving average of $2.29 and a 200 day moving average of $2.45.

Analysts Set New Price Targets

Several equities research analysts have issued reports on CLVT shares. Barclays increased their target price on Clarivate from $2.40 to $2.50 and gave the stock an “underweight” rating in a research report on Tuesday, July 7th. Wall Street Zen upgraded Clarivate from a “hold” rating to a “buy” rating in a research note on Saturday, May 2nd. Finally, Weiss Ratings reissued a “sell (e+)” rating on shares of Clarivate in a report on Wednesday, June 24th. Four investment analysts have rated the stock with a Hold rating and three have assigned a Sell rating to the company. Based on data from MarketBeat, the stock has an average rating of “Reduce” and an average price target of $2.98.

Institutional Trading of Clarivate

Hedge funds and other institutional investors have recently bought and sold shares of the company. PharVision Advisers LLC bought a new position in Clarivate during the third quarter valued at approximately $45,000. Pitcairn Co. purchased a new stake in shares of Clarivate in the 2nd quarter valued at $52,000. Jump Financial LLC purchased a new stake in shares of Clarivate in the 4th quarter valued at $41,000. Tower Research Capital LLC TRC boosted its stake in shares of Clarivate by 165.6% in the 2nd quarter. Tower Research Capital LLC TRC now owns 17,383 shares of the company’s stock valued at $75,000 after purchasing an additional 10,839 shares in the last quarter. Finally, RPO LLC bought a new position in shares of Clarivate during the 4th quarter valued at $64,000. Hedge funds and other institutional investors own 85.72% of the company’s stock.

About Clarivate

Clarivate plc is a global information and analytics company that provides insights and workflow solutions to accelerate the pace of innovation. The company delivers proprietary data, analytics, and expertise to support research and development in the life sciences, intellectual property management, academic institutions, government agencies, and corporations. Its core offerings include citation and patent databases, drug pipeline analytics, trademark research tools, regulatory compliance solutions, and market intelligence platforms.

Originally part of Thomson Reuters’ Intellectual Property & Science division, Clarivate was established as an independent entity in 2016 following a spin-off transaction.